Immunotherapy has the potential to treat almost any type of cancer. Learn how we are making this a reality for more patients sooner.
Cancer patients, donors, scientists, and other supporters all stand behind the Cancer Research Institute. Read their stories and learn about what motivates each of us to keep fighting against cancer.
Have a creative idea for a fundraiser you'd like to host to benefit cancer research? Or are you seeking ideas for how you can help us achieve our mission to conquer all cancers? Get inspired by our ideas and tips.
We gratefully accept donations made in memory or in honor of a loved one. Your gift will be acknowledged to whomever you specify.
Numerous challenges can derail progress in finding new immune-based cancer treatments. We're solving some of the biggest challenges, keeping promising new immunotherapies on the fast track to patients.
Cancer patients are now beginning to benefit from advances in cancer immunotherapy. Watch this story of hope and survival, and be inspired to help us conquer cancer.
Browse our directory of scientific leaders who volunteer their time and expertise to help ensure that we fund the most innovative and promising research possible.
Welcome to our blog. Here we share the latest updates from CRI, including scientific breakthroughs, news stories, and program announcements. We invite your comments and encourage you to share these stories with your friends.
You can receive notifications of new posts by subscribing to our blog. Just click the RSS icon in the upper right corner.
December 5, 2013
Battling acute lymphoblastic leukemia, 6-year-old Emily Whitehead was enrolled in a clinical trial led by CRI scientist Dr. Carl June.
Xueling Wu, a CRI postdoctoral fellow from 2003-2006, has recently been appointed an assistant professor at the Aaron Diamond AIDS Research Center at The Rockefeller University.
AIDS, HIV-1, vaccine, Xueling Wu
A breakthrough new treatment that genetically modifies immune cells in cancer patients is showing tremendous promise in helping adults with an aggressive form of leukemia.
gene therapy, leukemia, T cell therapy
The New York Observer named Cancer Research Institute Young Philanthropists Council chair Alexis Feldman as one of its "20 Under 40" Top Young Philanthropists in its 2013 annual philanthropy supplement.
alexis feldman, new york observer, young philanthropists
Mark Sundrud, a former CRI Irvington Postdoctoral Fellow (2006-2009) has been appointed assistant professor in the Department of Cancer Biology at The Scripps Research Institute.
fellows, mark sundrud, postdocs